The Multidisciplinary Approach to Renal Denervation: Current Evidences and Open Questions - European Medical Journal

The Multidisciplinary Approach to Renal Denervation: Current Evidences and Open Questions

Download PDF
*Sara Samoni, Marco Sartori, Elisa Scalzotto, Alessandra Brocca, Silvia Guggia, Francesco Ramponi, Mauro Neri, Paolo Armignacco, Grazia Maria Virzì, Maria Pia Rodighiero, Claudio Ronco

No potential conflict of interest.

EMJ Nephrol. ;1[1]:83-90. DOI/10.33590/emjnephrol/10312539.
Resistant hypertension, sympathetic hyperactivity, catheter, radiofrequency, heart failure, incremental cost effectiveness ratio.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


Renal denervation (RD) is a new clinical procedure which aims to treat resistant hypertensive patients. As with every new technology introduced into the clinical setting, many aspects were not explored sufficiently in order to be implemented into routine clinical practice. Advances in clinical technology require different steps of development, which start from preliminary in vitro experiments and finally arrive in the market, available for physicians when they have been proven to produce benefits for patients. Each stage usually takes many years before acquiring consensus from specialists involved in specific fields. In our opinion, this is a long and blind way and is a disadvantage to patients who need rapid, specific, and effective treatments. Otherwise, a multidisciplinary approach can provide the right evaluation of RD position and its potential for clinical application and research development. Therefore, we decided to draw a well-structured literature review from different specialists’ points of view in order to cover the subject in a translational manner. We reported animal models and experimental trials, in chronological order, and their evidences which have created the basis for human research. Technologies and devices were compared to underlined advantages and disadvantages. An update of clinical data was considered to define clinical needs in order to build focused trials. Furthermore, we evaluate the feasibility of routine RD clinical use by means of an economic analysis. Finally, we tried to settle the main unresolved questions and then assessed future RD perspectives, including non-hypertension indications.

Please view the full content in the pdf above.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now